Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks

Investing.com Gold reports: Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks. This is a premium/paywalled source, so the brief is based on headline and available metadata only.